Active Pharmaceutical Ingredient

Panitumumab API Manufacturer & Supplier in India

Also known as: Vectibix

CAS: 339177-26-3 Monoclonal Antibody IP / BP / EP / USP GMP Certified Aurangabad, Maharashtra, India
Panitumumab API — Mediocon Inc
Panitumumab — Pharmaceutical Grade API

Product Overview

CAS No: 339177-26-3  |  MF: C₆₄₇₄H₉₉₈₄N₁₇₂₄O₂₀₁₄S₄₄  |  MW: ~147,000 Da

Panitumumab is a pharmaceutical-grade active ingredient classified as a fully human monoclonal antibody targeting the epidermal growth factor receptor (EGFR). Mediocon Inc supplies high-purity Panitumumab API conforming to IP / BP / EP / USP specifications, manufactured in our GMP-certified facility in Aurangabad, Maharashtra, India.

Panitumumab binds specifically to EGFR on tumor cells, blocking ligand-binding and downstream signaling pathways that drive tumor growth. It is used for treatment of EGFR-expressing metastatic colorectal carcinoma in patients with wild-type KRAS gene.

Key Features

  • High-purity pharmaceutical grade API
  • IP/BP/EP/USP compliant
  • Full CoA and MSDS documentation
  • GMP certified manufacturing

Applications

  • Wild-type KRAS metastatic colorectal cancer
  • EGFR-expressing colorectal carcinoma
  • Oncology biologic formulations
  • Combination chemotherapy protocols

Why Choose Mediocon

  • ISO 9001:2015 & GMP certified manufacturing
  • Consistent batch-to-batch quality with full CoA
  • Export-ready documentation: COO, MSDS, DMF
  • Flexible MOQ for both R&D and commercial scale
  • Dedicated QA support for regulatory filings

Product Specifications

Product NamePanitumumab
Also Known AsVectibix
CAS Number339177-26-3
Molecular FormulaC₆₄₇₄H₉₉₈₄N₁₇₂₄O₂₀₁₄S₄₄
Molecular Weight~147,000 Da
CategoryMonoclonal Antibody — EGFR Inhibitor
AppearanceColorless to slightly opalescent solution
SolubilityFormulated as sterile aqueous solution
GradeIP / BP / EP / USP

Analytical Specifications

ParameterSpecification
AssayNLT 98.0%
Loss on DryingNMT 0.5%
Heavy MetalsNMT 20 ppm
Residue on IgnitionNMT 0.1%
Microbial LimitsComplies with pharmacopoeia
IdentificationIR, HPLC Compliant
Packing25 kg HDPE drums / as per requirement

Sourcing, Regulatory & Export Information

Mediocon Inc is a GMP-certified API manufacturer and bulk pharmaceutical ingredient supplier based in Aurangabad, Maharashtra, India. We specialise in supplying Panitumumab (CAS 339177-26-3) and over 1,000 other Active Pharmaceutical Ingredients, excipients, herbal extracts, and nutraceutical ingredients to pharmaceutical manufacturers worldwide.

Our Panitumumab is manufactured under strict quality management protocols compliant with WHO-GMP, ISO 9001:2015, and major pharmacopoeial standards (IP, BP, USP, EP). Every batch undergoes full analytical testing — identity (IR/HPLC), assay, related substances, residual solvents (ICH Q3C), heavy metals, and microbial limits — before release with a Certificate of Analysis.

Export Markets

  • USA — FDA-registered facility; DMF support available for ANDA/NDA filings
  • Europe — EMA-compliant documentation; CEP/EDMF support on request
  • Africa & Middle East — WHO-GMP certified; competitive pricing for emerging markets
  • Southeast Asia — established logistics network; temperature-controlled shipments
  • India domestic — schedule H/X compliance; all state licensing documentation provided

Quality & Compliance

  • ISO 9001:2015 certified quality management system
  • GMP-certified manufacturing facility, Aurangabad, Maharashtra
  • Full batch traceability from raw material to finished API
  • Stability data available (ICH Q1A guidelines) for regulatory submissions
  • Dedicated QA team for customer audits and regulatory queries

Frequently Asked Questions — Panitumumab API

What is the minimum order quantity for Panitumumab API?
Mediocon Inc supplies Panitumumab with a minimum order quantity of 1 kg (sample packs available for R&D). We accommodate both small R&D quantities and large commercial-scale orders. Contact our sales team at akshay@mediocon.com or +91 9309999757 for a tailored quote.
What pharmacopoeial grades of Panitumumab does Mediocon supply?
We supply Panitumumab conforming to IP / BP / EP / USP pharmacopoeial standards. Each batch is tested against full pharmacopoeial specifications and released with a Certificate of Analysis. Custom specifications can be accommodated for regulated markets.
What documentation is provided with Panitumumab API?
Every shipment of Panitumumab comes with: Certificate of Analysis (CoA), MSDS/SDS, Certificate of Origin (COO), and Drug Master File (DMF) support on request. We also provide GMP certification, ISO 9001:2015 compliance documentation, and full regulatory support for filings in USA (FDA), Europe (EMA), and other markets.
What is the lead time and shipping for Panitumumab bulk orders?
Standard lead time for Panitumumab is 2–4 weeks for standard orders; expedited shipments possible for urgent requirements. We ship to 40+ countries worldwide using approved pharmaceutical-grade packaging (25 kg HDPE drums / aluminium foil bags). All shipments include temperature-controlled logistics options where required by the product's storage conditions.
💬
Mediocon AI
Hello 👋 How can I help you today?